Tilray Reckons Sales Won't Be Dented by Tariffs -- Market Talk

Dow Jones
2025/04/08

0806 ET - Tilray Brands, whose cannabis and drinks business straddles Canada and the U.S., says it doesn't anticipate a hit to sales from import tariffs after it conducted an analysis of the potential implications on its business. In the U.S., Tilray says its American beverage brands are solely manufactured and distributed within the U.S. market. In Canada, Tilray's cannabis brands are produced domestically for Canadian consumers. in Europe, Tilray manufactures medical cannabis brands and products for distribution across Europe and Australia. Chairman and CEO Irwin Simon says there continues to be opportunities in the alcohol, cannabis, and wellness industries. Tilray also sees a future in digital currencies and plans to accept cryptocurrency as a payment method online and says it is exploring strategic initiatives related to cryptocurrency. (robb.stewart@wsj.com)

(END) Dow Jones Newswires

April 08, 2025 08:06 ET (12:06 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10